Cargando…

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics

Detalles Bibliográficos
Autores principales:	Bapiro, Tashinga E., Hayeshi, Rose, Dandara, Collet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372610/ https://www.ncbi.nlm.nih.gov/pubmed/35965582 http://dx.doi.org/10.3389/fonc.2022.972718

Ejemplares similares

Understanding the Complexity of Porous Graphitic Carbon (PGC) Chromatography: Modulation of Mobile-Stationary Phase Interactions Overcomes Loss of Retention and Reduces Variability
por: Bapiro, Tashinga E., et al.
Publicado: (2016)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
por: Liu, Yao, et al.
Publicado: (2022)

Editorial: Host-pathogen interactions interplay and cancer: understanding mechanisms and beyond
por: Khan, Abdul Arif, et al.
Publicado: (2023)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Editorial: Anti-cancer drug delivery: lipid-based nanoparticles
por: Alkilany, Alaaldin M., et al.
Publicado: (2023)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression
por: Yang, Yongyong, et al.
Publicado: (2023)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
por: Yan, Miao, et al.
Publicado: (2023)

MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications
por: Swart, Marelize, et al.
Publicado: (2019)

The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
por: Yu, Yina, et al.
Publicado: (2020)

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
por: Courtin, Aurélie, et al.
Publicado: (2013)

Editorial: Women in pharmacology of anti-cancer drugs: 2021
por: Giovannetti, Elisa
Publicado: (2022)

Editorial: Insights in pharmacology of anti‐cancer drugs: 2021
por: Sancho, Patricia, et al.
Publicado: (2022)

Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs
por: Wen, Hai-ni, et al.
Publicado: (2022)

Mechanical and metabolic interplay in the brain metastatic microenvironment
por: Onwudiwe, Killian, et al.
Publicado: (2022)

Editorial: Metabolic Plasticity of Cancer
por: Rodríguez-Enríquez, Sara, et al.
Publicado: (2020)

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

Editorial: Reviews in cancer metabolism
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2023)

Metabolic Aspects of Palladium(II) Potential Anti-Cancer Drugs
por: Carneiro, Tatiana J., et al.
Publicado: (2020)

The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
por: Singh, Reema, et al.
Publicado: (2021)

An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
por: Qin, Albert
Publicado: (2023)

Editorial: Redox and Metabolic Circuits in Cancer
por: Rizza, Salvatore, et al.
Publicado: (2018)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
por: Pasello, Giulia, et al.
Publicado: (2022)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
por: Khan, Husain Yar, et al.
Publicado: (2023)

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
por: Wang, Lishun, et al.
Publicado: (2023)

Editorial: Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
por: Riganti, Chiara, et al.
Publicado: (2015)

Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer
por: Giacomini, Isabella, et al.
Publicado: (2022)

Editorial: Interplay between RNA-binding proteins and non-coding RNAs in tumor therapeutic resistance
por: Dong, Peixin, et al.
Publicado: (2023)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Editorial: Cancer Metabolism: Current Knowledge and Perspectives
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2019)

Editorial: The Role of lncRNA in Cancer Metabolism
por: Huang, Guo-Liang, et al.
Publicado: (2021)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Editorial: Women in cancer metabolism: 2021/2022
por: Kaambre, Tuuli
Publicado: (2022)

Editorial: Rising stars in cancer metabolism 2022
por: Izquierdo-Garcia, Jose Luis, et al.
Publicado: (2023)

Integrative Analysis of Pharmacokinetic and Metabolomic Profiles for Predicting Metabolic Phenotype and Drug Exposure Caused by Sotorasib in Rats
por: Du, Ping, et al.
Publicado: (2022)

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
por: Neesse, Albrecht, et al.
Publicado: (2014)

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022)

Imaging Sub-Cellular Methionine and Insulin Interplay in Triple Negative Breast Cancer Lipid Droplet Metabolism
por: Fung, Anthony A., et al.
Publicado: (2022)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nr9gmhthgi8lpf8tmn1o112tun